Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia

Mehr Informationen
Referenzen
Diskussion
Dateien

Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia - RWTH-2022-06965

Main document Datei(en):

Ähnliche Datensätze

h1

h2

h3

h4

h5

h6

RWTH

Kontakt

RWTH Publications

Allgemeines